Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer
Status:
Recruiting
Trial end date:
2021-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to define whether 6 courses of neoadjuvant chemotherapy can lead
to a higher rate of complete cytoreductive surgery compared with 3 courses of neoadjuvant
chemotherapy in patients with epithelial ovarian cancer, fallopian tube cancer or primary
peritoneal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi IRCCS Azienda Ospedaliero-Universitaria di Bologna